123 related articles for article (PubMed ID: 6796288)
1. The effects of lidoflazine on exercise performance and thallium stress scintigraphy in patients with stable angina pectoris.
Shapiro W; Narahara KA; Park J
Circulation; 1982 Jan; 65(1 Pt 2):I43-50. PubMed ID: 6796288
[TBL] [Abstract][Full Text] [Related]
2. Improved exercise myocardial perfusion during lidoflazine therapy.
Shapiro W; Narahara KA; Park J
Angiology; 1983 Nov; 34(11):705-10. PubMed ID: 6638605
[TBL] [Abstract][Full Text] [Related]
3. Lidoflazine in the management of angina pectoris.
Bloem TJ; Vermeulen A; Reneman RS
Clin Cardiol; 1979 Dec; 2(6):407-12. PubMed ID: 397016
[TBL] [Abstract][Full Text] [Related]
4. Lidoflazine and physical training in the treatment of stable angina pectoris.
Ferguson RJ; Côté P; Bourassa MG; Corbara F
Clin Cardiol; 1979 Dec; 2(6):413-6. PubMed ID: 397017
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of lidoflazine in angina pectoris. A long-term double-blind study].
Lehmann H; Hochrein H
Med Klin; 1976 Jan; 71(5):189-96. PubMed ID: 814396
[TBL] [Abstract][Full Text] [Related]
6. [Acute effects of transdermal administration of nitroglycerin on effort tolerance and myocardial perfusion, evaluated by Tl-201 scintigraphy, in patients with stable effort angina].
Novo S; Liquori M; Abrignani MG; Giuliano F; Panno V; Fazio M; Adamo L; Corda M; Indovina A; di Maria G
Cardiologia; 1991 Sep; 36(9):693-702. PubMed ID: 1802393
[TBL] [Abstract][Full Text] [Related]
7. Effect of gallopamil on myocardial microperfusion in patients with stable effort angina: a randomized, cross-over, double-blind, placebo-controlled trial.
Acanfora D; Vitale DF; Rengo C; Iannuzzi GL; Furgi G; Picone C; Rossi M; Trojano L; Rengo F
Cardiology; 1997; 88(4):353-60. PubMed ID: 9197430
[TBL] [Abstract][Full Text] [Related]
8. The effect of lidoflazine on exercise tolerance in patients with angina pectoris.
Nordstrom LA; Globel FL
Chest; 1978 Jul; 74(1):50-4. PubMed ID: 352634
[TBL] [Abstract][Full Text] [Related]
9. Beneficial and detrimental effects of lidoflazine in microvascular angina.
Cannon RO; Brush JE; Schenke WH; Tracy CM; Epstein SE
Am J Cardiol; 1990 Jul; 66(1):37-41. PubMed ID: 2193496
[TBL] [Abstract][Full Text] [Related]
10. Randomized, placebo-controlled evaluation of lidoflazine in patients receiving beta-blocker therapy with propranolol: improvement in anginal symptoms and exercise tolerance with combined drug therapy.
Strauss WE; Parisi AF
Am J Cardiol; 1984 Apr; 53(8):1003-7. PubMed ID: 6422735
[TBL] [Abstract][Full Text] [Related]
11. Angina pectoris: effects of lidoflazine on exercise tolerance and chest pain.
Jenkins MD; Swallow EA; Abdel-Hadi O; Kidner PH
Am J Cardiol; 1981 Jul; 48(1):140-6. PubMed ID: 7246436
[TBL] [Abstract][Full Text] [Related]
12. The pathophysiology of angina pectoris and the effect of lidoflazine.
Gobel FL; Nordstrom LA; Nelson RR; Wang Y
Circulation; 1982 Jan; 65(1 Pt 2):I27-32. PubMed ID: 7030519
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of lidoflazine as an anti-anginal drug.
Vohra JK; Sloman JG
Cardiology; 1973; 58(4):209-19. PubMed ID: 4206284
[No Abstract] [Full Text] [Related]
14. Comparison of chest pain, electrocardiographic changes and thallium-201 scintigraphy during varying exercise intensities in men with stable angina pectoris.
Heller GV; Ahmed I; Tilkemeier PL; Barbour MM; Garber CE
Am J Cardiol; 1991 Sep; 68(6):569-74. PubMed ID: 1877474
[TBL] [Abstract][Full Text] [Related]
15. Postinfarction exercise capacity after lidoflazine treatment or physical training.
Degré S; Lenaers A; Messin R; Vandermoten P; Salhadin P; Limage M; Denolin H
Cardiology; 1979; 64(1):35-47. PubMed ID: 365332
[TBL] [Abstract][Full Text] [Related]
16. [Changes in myocardial perfusion in ischemic heart disease as affected by nitrong].
Kramer AA; Gasilin VS; Samoĭlenko LE
Kardiologiia; 1980 Nov; 20(11):76-9. PubMed ID: 6777575
[TBL] [Abstract][Full Text] [Related]
17. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography.
Mahmarian JJ; Fenimore NL; Marks GF; Francis MJ; Morales-Ballejo H; Verani MS; Pratt CM
J Am Coll Cardiol; 1994 Jul; 24(1):25-32. PubMed ID: 8006274
[TBL] [Abstract][Full Text] [Related]
18. [Effects of gallopamil on iodine-123-phenyl-pentadecanoic acid and thallium 201 uptake in patients with coronary heart disease].
Tillmanns H; Zimmermann R; Kapp M; Rauch B; Neumann FJ; Schlumpp K; Bubeck B; Georgi P; Kübler W
Z Kardiol; 1989; 78 Suppl 5():77-82. PubMed ID: 2698567
[TBL] [Abstract][Full Text] [Related]
19. Double-blind trial of nifedipine in angina patients with normal coronary arteries.
Pitcher D; Sowton E
Pharmatherapeutica; 1981; 3(1):6-13. PubMed ID: 6798584
[TBL] [Abstract][Full Text] [Related]
20. A double-blind clinical and ECG-evaluation of lidoflazine (R 7904) in the treatment of stabilized angina pectoris.
Keulen UW
Curr Med Res Opin; 1973; 1(8):469-81. PubMed ID: 4589632
[No Abstract] [Full Text] [Related]
[Next] [New Search]
